17 Hepatitis C and renal disease

Zacks, Steven; Fried, Michael

doi:10.1016/s1874-5326(00)80021-6

Cited by 2 publications

(3 citation statements)

References 78 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Over the last decade it has become increasingly apparent that routinely recommended serological and biochemical tests may fail to reveal active HCV infection in this population (Saab et al, 2001a,b;Zacks andFried, 2000, 2001). HCV-infected HD patients may test negative for HCV antibodies either because of early stage of infection or because their compromised immune system is unable to mount an antibody response (Almroth et al, 2002;Hanuka et al, 2002).…”

Section: Introductionmentioning

confidence: 99%

Improved detection of HCV Infection in hemodialysis patients using a new HCV RNA qualitative assay: experience of a transplant center

Khan¹,

Aswad²,

Shidban³

et al. 2004

Journal of Clinical Virology

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 99%

Improved detection of HCV Infection in hemodialysis patients using a new HCV RNA qualitative assay: experience of a transplant center

Khan¹,

Aswad²,

Shidban³

et al. 2004

Journal of Clinical Virology

View full text Add to dashboard Cite

“…Alpha interferon alone or in combination with ribavirin is FDA-approved for the treatment of chronic hepatitis C (48,140,141 ). Combination therapy should be used with caution in patients with creatinine clearance <50 mL/minute and generally is contraindicated in patients with renal failure (141,142 ). Interferon monotherapy results in low sustained virologic response rates (141,142 ).…”

Section: Mmwr 11mentioning

confidence: 99%

“…Combination therapy should be used with caution in patients with creatinine clearance <50 mL/minute and generally is contraindicated in patients with renal failure (141,142 ). Interferon monotherapy results in low sustained virologic response rates (141,142 ).…”

Section: Mmwr 11mentioning

confidence: 99%

Recommendations for Preventing Transmission of Infections Among Chronic Hemodialysis Patients

Alter¹,

Arduino²,

Lyerla³

et al. 2001

PsycEXTRA Dataset

126

View full text Add to dashboard Cite

Acute hepatitis B Newly acquired symptomatic hepatitis B virus (HBV) infection. Acute hepatitis C Newly acquired symptomatic hepatitis C virus (HCV) infection. ALT Alanine aminotransferase, previously called SGPT. Anti-HBc Antibody to hepatitis B core antigen. Anti-HBe Antibody to hepatitis B e antigen. Anti-HBs Antibody to hepatitis B surface antigen. Anti-HCV Antibody to hepatitis C virus. Anti-HDV Antibody to hepatitis D virus. AST Aspartate aminotransferase, previously called SGOT. AV Arteriovenous. Chronic (persistent) HBV infection Persistent infection with HBV; characterized by detection of HBsAg >6 months after newly acquired infection. Chronic (persistent) HCV infection Persistent infection with HCV; characterized by detection of HCV RNA >6 months after newly acquired infection. Chronic hepatitis B Liver inflammation in patients with chronic HBV infection; characterized by abnormal levels of liver enzymes. Chronic hepatitis C Liver inflammation in patients with chronic HCV infection; characterized by abnormal levels of liver enzymes. CNS Coagulase negative staphylococci. EIA Enzyme immunoassay. EPA U.S. Environmental Protection Agency. ESRD End-stage renal disease. FDA U.S. Food and Drug Administration. GISA Glycopeptide-resistant Staphylococcus aureus. HBcAg Hepatitis B core antigen HBeAg Hepatitis B e antigen. HBsAg Hepatitis B surface antigen. HBV Hepatitis B virus. HBV DNA Hepatitis B virus deoxyribonucleic acid. HCV Hepatitis C virus. HCV RNA Hepatitis C virus ribonucleic acid. HDV Hepatitis D virus. HIV Human immunodeficiency virus. Isolated anti-HBc Anti-HBc positive, HBsAg negative, and anti-HBs negative. MRSA Methicillin-resistant Staphylococcus aureus. NNIS National Nosocomial Infections Surveillance system. RIBA™ Recombinant immunoblot assay. RT-PCR Reverse transcriptase polymerase chain reaction. SGOT Serum glutamic-oxaloacetic transaminase, now called AST. SGPT Serum glutamic-pyruvic transaminase, now called ALT. VISA Vancomycin-intermediate Staphylococcus aureus. VRE Vancomycin-resistant enterococci.

show abstract

17 Hepatitis C and renal disease

Cited by 2 publications

References 78 publications

Improved detection of HCV Infection in hemodialysis patients using a new HCV RNA qualitative assay: experience of a transplant center

Improved detection of HCV Infection in hemodialysis patients using a new HCV RNA qualitative assay: experience of a transplant center

Recommendations for Preventing Transmission of Infections Among Chronic Hemodialysis Patients

Contact Info

Product

Resources

About